Devos H, Vandenberghe W, Nieuwboer A, Tant M, Baten G, De Weerdt W
Katholieke Universiteit Leuven, Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation Sciences, Tervuursevest 101, BE-3001 Leuven, Belgium.
Neurology. 2007 Oct 2;69(14):1434-41. doi: 10.1212/01.wnl.0000277640.58685.fc.
To develop an efficient clinical screening battery to accurately predict the fitness to drive in people with Parkinson disease (PD).
This prospective study included 80 participants: 40 patients with PD and 40 healthy age- and sex-matched control subjects. All participants were assessed using a driving simulator, a driving history survey, and the Clinical Dementia Rating. The patients with PD also underwent a clinical test battery and an evaluation of fitness to drive performed by an official center, which included visual, cognitive, and on-road tests. A two-class decision from this driving assessment center was the main outcome measure.
A screening battery assessing four clinical variables (disease duration, contrast sensitivity, Clinical Dementia Rating, and motor part of the Unified Parkinson's Disease Rating Scale) provided the best model (R(2) = 0.52) to predict the fitness to drive and correctly classified 36 (90%) of the patients with PD as pass or fail (sensitivity = 91%, specificity = 90%). The Test Ride for Investigating Practical fitness to drive (TRIP) driving simulator score discriminated significantly between drivers with PD and their healthy peers (p = 0.0008). When the TRIP driving simulator score was added to the clinical model, the total explained variance increased (R(2) = 0.60) and correctly classified 39 (97.5%) of drivers with PD into the pass/fail category (sensitivity = 91%, specificity = 100%).
A short clinical screening battery that measures disease duration, contrast sensitivity, cognitive and motor functions can predict fitness to drive in people with Parkinson disease with a high degree of accuracy.
开发一种高效的临床筛查组合,以准确预测帕金森病(PD)患者的驾驶适宜性。
这项前瞻性研究纳入了80名参与者:40名PD患者和40名年龄及性别匹配的健康对照者。所有参与者均使用驾驶模拟器、驾驶史调查问卷和临床痴呆评定量表进行评估。PD患者还接受了一组临床测试以及由官方中心进行的驾驶适宜性评估,其中包括视觉、认知和道路测试。来自该驾驶评估中心的两类判定是主要结局指标。
评估四个临床变量(病程、对比敏感度、临床痴呆评定量表以及统一帕金森病评定量表的运动部分)的筛查组合提供了预测驾驶适宜性的最佳模型(R² = 0.52),并将36名(90%)PD患者正确分类为通过或未通过(敏感度 = 91%,特异度 = 90%)。用于调查实际驾驶适宜性的试驾(TRIP)驾驶模拟器得分在PD患者与其健康同龄人之间存在显著差异(p = 0.0008)。当将TRIP驾驶模拟器得分添加到临床模型中时,总解释方差增加(R² = 0.60),并将39名(97.5%)PD患者正确分类为通过/未通过类别(敏感度 = 91%,特异度 = 100%)。
一种测量病程、对比敏感度、认知和运动功能的简短临床筛查组合能够高度准确地预测帕金森病患者的驾驶适宜性。